NOTE: CME is no longer available for this activity.

This self-study continuing medical education activity is designed to provide urologists, Board candidates and/or residents affordable and convenient access to the most recent developments and techniques in urology.
 
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Credit Designation: The American Urological Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
 
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME enduring material activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
 
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
 
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

• Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor and/or Education Content Review Committee or its subgroup.
• Limit content to evidence with no recommendations
• Introduction of a debate format with an unbiased moderator (point-counterpoint)
• Inclusion of moderated panel discussion
• Publication of a parallel or rebuttal article for an article that is felt to be biased
• Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
• Divestiture of the relationship by faculty

Disclosures
Individual authors’ disclosures are located with their articles in each issue of The Update Series.

Planner Disclosures

Victor Nitti, MD: Astellas: Health Publishing, Scientific Study or Trial; Allergan: Health Publishing, Scientific Study or Trial; Serenity Pharmeuticals: Investment Interest; Cook Myosite: Scientific Study or Trial
Brant Inman, MD, MS: Dendreon: Scientific Study or Trial; Abbott Laboratories: Scientific Study or Trial; Genentech, Inc.: Scientific Study or Trial; Combat Medical: Consultant or Advisor; FKD Therapies: Scientific Study or Trial; AstraZeneca: Consultant or Advisor; Taris Biomedical: Consultant or Advisor

Update Series Advisory Group

Name	Company	Role
Arthur Louis Burnett II, MD, MBA	Endo Pharmaceuticals	Scientific Study or Trial
	PFIZER	Scientific Study or Trial
	National Institutes of Health	Scientific Study or Trial
	Auxilium Inc	Scientific Study or Trial
	American Medical Systems	Scientific Study or Trial
	Coloplast	Scientific Study or Trial
	Urology Times Editorial Council	Health Publishing
	Lilly LLC	Consultant or Advisor, Scientific Study or Trial
	International Urology and Nephrology (journal)	Health Publishing
	Genomic Health Inc	Consultant or Advisor
	Practical Reviews in Urology	Health Publishing
	European Urology	Health Publishing
	Medispec	Scientific Study or Trial
	Astellas	Consultant or Advisor, Scientific Study or Trial
	Reflexonic LLC	Scientific Study or Trial
	VIVUS	Health Publishing, Scientific Study or Trial
	Acorda Therapeutics	Scientific Study or Trial
	The Center for Intimacy after Cancer Therapy, Inc	Leadership Position
	Journal of Sexual Medicine	Health Publishing
	Andrology (journal)	Health Publishing
Rodney Davis, MD	Corrections Corp of America	Consultant or Advisor, Investment Interest
Shelby Englert	Nothing to disclose
E. Ann Gormley, MD	SUFU Foundation	Leadership Position
	ACGME	Leadership Position
	ABMS	Leadership Position
J. Kellogg Parsons, MD	MDx Health	Consultant or Advisor
	Endocare	Consultant or Advisor
Cheryl Taylore Lee, MD	Nothing to disclose
David Christopher Miller, MD, MPH	Blue Cross Blue Shield of Michigan	Other
	National Cancer Institute	Scientific Study or Trial
Curtis Nickel, MD	Farr Laboratories	Consultant or Advisor
	Tribute	Consultant or Advisor
	Aquinox	Scientific Study or Trial
	GSK	Scientific Study or Trial
	PureTech Health	Consultant or Advisor
	AUA	Health Publishing
	NIH	Scientific Study or Trial
	Canadian Institute of Health Research	Scientific Study or Trial
	Interface Biologics	Consultant or Advisor
	Alvio Therapeutics	Consultant or Advisor
	Seikagaku Corporation	Consultant or Advisor
Craig Stuart Niederberger, MD	AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE	Leadership Position, Meeting Participant or Lecturer
	NexHand	Leadership Position, Investment Interest, Owner, Product Development
	Ferring Pharmaceuticals	Scientific Study or Trial
Victor William Nitti, MD	Astellas	Health Publishing, Scientific Study or Trial
	Allergan	Health Publishing, Scientific Study or Trial
	Serenity Pharmeuticals	Investment Interest
	Cook Myosite	Scientific Study or Trial
	Medtronic	Scientific Study or Trial
Mrs. Deborah F. Polly	Nothing to disclose
Eila Curlee Skinner, MD	Nothing to disclose
Stacy T. Tanaka, MD	AUA Update Series	Health Publishing
	Journal of Urology	Health Publishing
	Centers for Disease Control and Prevention (CDC)	Scientific Study or Trial
	Centers for Disease Control and Prevention (CDC)	Scientific Study or Trial
J. Christian Winters, MD	Astellas, Inc	Consultant or Advisor
	Allergan	Consultant or Advisor
	Society of Urodynamics, Female Pelvic Medicine and Urogential Reconstruction	Leadership Position
	Solace	Scientific Study or Trial
	StimGuard	Consultant or Advisor
J. Stuart Wolf Jr., MD., FACS	Urology Times	Health Publishing
	University of Texas Department of Surgery & Peri-operative Care	Leadership Position

Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
 
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
 
Reproduction Permission: Reproduction of written materials developed for this AUA activity is prohibited without the written permission from individual authors and the American Urological Association.
 
Peer Review: Peer review is the principle mechanism by which the quality of the AUA Update Series content is judged by the AUA Update Series Advisory Board.

Release date: March 2018

Expiration date: March 2021